Inhibition of the STAT6/ANO1 pathway reduced proliferation, migration, and invasion by gastric cancer cells, suggesting that the STAT6/ANO1 pathway could represent a novel therapeutic target for gastric cancer. This evidence concerns the gene ANO1 and gastric cancer.